Olfactory marker protein regulation of glucagon secretion in hyperglycemia.
Ju Hun OhYe Eon HanYa Ru BaoChan Woo KangJaeHyung KooCheol-Ryong KuYoon Hee ChoEun Jig LeePublished in: Experimental & molecular medicine (2022)
The olfactory marker protein (OMP), which is also expressed in nonolfactory tissues, plays a role in regulating the kinetics and termination of olfactory transduction. Thus, we hypothesized that OMP may play a similar role in modulating the secretion of hormones involved in Ca 2+ and cAMP signaling, such as glucagon. In the present study, we confirmed nonolfactory α-cell-specific OMP expression in human and mouse pancreatic islets as well as in the murine α-cell line αTC1.9. Glucagon and OMP expression increased under hyperglycemic conditions. Omp knockdown in hyperglycemic αTC1.9 cells using small-interfering RNA (siRNA) reduced the responses to glucagon release and the related signaling pathways compared with the si-negative control. The OMP lox/lox ;GCG cre/w mice expressed basal glucagon levels similar to those in the wild-type OMP lox/lox mice but showed resistance against streptozotocin-induced hyperglycemia. The ectopic olfactory signaling events in pancreatic α-cells suggest that olfactory receptor pathways could be therapeutic targets for reducing excessive glucagon levels.
Keyphrases
- induced apoptosis
- wild type
- diabetic rats
- binding protein
- signaling pathway
- poor prognosis
- cell cycle arrest
- oxidative stress
- endothelial cells
- endoplasmic reticulum stress
- gene expression
- low density lipoprotein
- single cell
- high fat diet induced
- adipose tissue
- high fat diet
- physical activity
- body mass index
- drug delivery
- epithelial mesenchymal transition
- mesenchymal stem cells
- bone marrow
- ionic liquid
- diabetic nephropathy